Article · UK Corporate Tax & R&D
How CTA 2009 ss. 1133, 1138A, 1042I Step 3, and 1112E work in practice, with a complete worked trigger showing the 15% connected-party IP cliff
For accounting periods beginning on or after 1 April 2024, three statutory filters in CTA 2009 Part 13 trigger the largest unexpected disallowances in UK R&D claims: the new decision-maker / contemplated rule for contracted-out R&D (s. 1133), the UK territorial restriction on overseas subcontractors and EPWs (s. 1138A), and the PAYE/NIC cap and 15% connected-party IP exemption cliff (s. 1042I Step 3 & s. 1112E).
Under Finance Act 2024, the party who decided to undertake the R&D claims the relief. Where a customer enters into a contract and it is reasonable to assume the customer intended or contemplated that R&D of that sort would be undertaken to meet contractual obligations, the customer claims (s. 1042E for Merged RDEC / s. 1053 for ERIS, at 65% for unconnected subcontractors) and the contractor cannot claim. The key carve-out is CTA 2009 section 1042F (Merged RDEC) and section 1053A (ERIS): if the customer is an irrelievable / ineligible person (such as an overseas corporation outside UK CT, a charity, university, or government body), the UK contractor can claim Merged RDEC or (if an eligible loss-making R&D-intensive SME) ERIS.
Subcontracted R&D must be physically performed in the UK, and Externally Provided Workers (EPWs) must be subject to UK PAYE and Class 1 NIC. Overseas expenditure qualifies under s. 1138A(2) only if geographical, environmental, social, or legal/regulatory conditions necessary for the R&D are absent in the UK, present overseas, and wholly unreasonable to replicate in the UK. Under section 1138A(4), cost and worker availability are expressly barred.
Clyde Robotics Systems Ltd incurs £1,445,000 in gross project spend during FY2025, but loses £180,000 (Polish cost-driven firmware under s. 1138A(4)) and £220,000 (UK aerospace customer-contemplated contract under s. 1133), leaving £840,000 of qualifying R&D (intensity 24.00% < 30%, placing Clyde in Merged RDEC). Worse, Clyde's connected UK EPW spend (£160,000) equals 19.05% of qualifying R&D, breaching the 15% ceiling (s. 1112E) and disqualifying the IP exemption:
| Clyde Robotics Systems Ltd (FY2025) | Actual (Cap Applies) | If IP Exempt (<= 15%) |
|---|---|---|
| Qualifying R&D Expenditure | £840,000 | £840,000 |
| Gross Merged RDEC (20%) - IAS 20 Other Operating Income | £168,000 | £168,000 |
| Step 2 Notional Tax (19% Loss Rate, CF s. 1042L) | £31,920 | £31,920 |
| Net Credit Entering Step 3 | £136,080 | £136,080 |
| PAYE/NIC Cap (£20,000 + 300% x £30,000) | £110,000 | Exempt |
| Step 3 Capped Credit Carried Forward (s. 1042J(2) / s. 1042K(9)) | £26,080 | £0 |
| Step 7 Immediate Cash Payable | £110,000 (13.10%) | £136,080 (16.20%) |
Under Merged RDEC, Clyde's £26,080 Step 3 restriction is not lost permanently: under CTA 2009 s. 1042J(2), it rolls forward to Step 1 of Year 2 (excluded from a second Step 2 charge under s. 1042K(9)) and can convert to cash next year once PAYE/NIC headroom increases or connected EPW spend drops below 15%.
Run your own UK R&D figures through the live 7-step Merged RDEC, ERIS 30% intensity, and PAYE/NIC cap model in UK_RD_Merged_RDEC_ERIS_Calculator.xlsx, or read the complete 15-chapter practitioner reference in The UK R&D Tax Relief Handbook.
Read also: UK Merged RDEC 20% Seven-Step Calculation
Read also: UK ERIS 30% R&D Intensity Test and 14.5% Payable Credit
Related UK corporate tax handbooks: UK Corporate Interest Restriction · UK VAT Partial Exemption · OECD Pillar Two